ArticleAntibiotics (Basel, Switzerland)2019

Molecular Characterization and Moxifloxacin Susceptibility of Clostridium difficile.

Sarah Mizrahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.